Laura Gillespie Selected Research

Laura Gillespie Research Topics

5	COVID-19 01/2022 - 01/2021
1	Hemorrhagic Shock 02/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Infections 01/2022
1	Hemorrhage 07/2021
1	Thrombosis (Thrombus) 07/2021
1	Pulmonary Infarction 04/2021
1	Venous Thromboembolism 04/2021
1	Hematoma 04/2021
1	Embolism (Embolus) 04/2021
1	Thrombophilia 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Papillomavirus Infections 04/2011

3	Hemostatics (Antihemorrhagics)IBA 02/2022 - 01/2021
2	Heparin (Liquaemin)FDA LinkGeneric 07/2021 - 04/2021
2	AnticoagulantsIBA 04/2021 - 01/2021
1	fibrin fragment D (D-dimer)IBA 07/2021
1	Fibrinogen (Factor I)FDA Link 07/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 07/2021
1	Warfarin (Coumadin)FDA LinkGeneric 04/2021
1	vinyltriethoxysilane (VTES)IBA 04/2021
1	factor V LeidenIBA 01/2021
1	VaccinesIBA 04/2011

2	Therapeutics 04/2021 - 04/2021
1	Liver Transplantation 02/2022
1	Resuscitation 01/2022
1	Operative Surgical Procedures 01/2022